Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression-free survival without the adverse effects of steroid-based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.
Keywords: curcumin; dexamethasone intolerance; multiple myeloma.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.